7.2 Gallium, Thallium, Xenon, and Miscellaneous Agents
Key Takeaways
- Ga-67 citrate (t½ ≈ 78 h; gammas near 93, 185, 300, and 394 keV) behaves as an iron analog bound to transferrin; classic uses are infection/inflammation and selected tumors (use declining but still tested)
- Tl-201 thallous chloride (t½ ≈ 73 h; Hg x-rays ~69–83 keV and 167 keV gamma) is a K+ analog via Na+/K+ ATPase with redistribution—historical MPI and viability teaching staple
- Xe-133 gas (t½ ≈ 5.3 d; 81 keV) is an inert ventilation agent requiring negative-pressure room control, exhaust, and trap/charcoal systems
- Vs Tc alternatives: MPI now usually Tc-99m sestamibi/tetrofosmin; infection often Tc- or In-labeled WBCs or FDG PET; ventilation often Tc-99m DTPA aerosol/Technegas where available
- Traps: multi-peak Ga-67 window setup, Tl-201 soft-tissue attenuation and long biologic retention teaching points, and xenon room contamination or missing trap checks
7.2 Gallium, Thallium, Xenon, and Miscellaneous Agents
Quick Answer: Ga-67 citrate → iron/transferrin pathway for infection and selected tumors (multi-energy, ~78 h). Tl-201 → K+ analog (Na+/K+ ATPase) with redistribution for historical MPI/viability. Xe-133 → inert ventilation gas (81 keV) with negative-pressure room + trap. Know why Tc/PET alternatives often win clinically—and why exams still ask these nuclides.
Gallium-67 Citrate
Physics and Mechanism
Ga-67 decays by electron capture with a physical half-life of about 78 hours (~3.3 days). Principal gammas used for imaging cluster near 93, 185, 300, and 394 keV—cameras need correct multi-energy window setup and often medium-energy collimation.
After IV injection as gallium citrate, gallium behaves as an iron analog: it binds transferrin in plasma and localizes at sites of infection/inflammation and some tumors via increased blood flow, capillary permeability, lactoferrin binding in neutrophils, and siderophore-related bacterial uptake pathways (exam-level simplification: iron-analog / transferrin-mediated localization).
| Item | Typical teaching values |
|---|---|
| Half-life | ≈ 78 h |
| Energies | 93, 185, 300, 394 keV (multi-peak) |
| Adult activity | Often ~5–10 mCi (185–370 MBq) IV |
| Imaging times | ~24, 48, and sometimes 72 h (infection protocols vary) |
| Excretion notes | Bowel and urinary activity—delayed imaging and bowel prep may help |
Indications (Still Tested)
- Fever of unknown origin / chronic infection workups (especially when labeled WBC imaging is limited)
- Osteomyelitis (selected contexts; spinal infection historically)
- Lymphoma and other tumors (historical staging/restaging—largely superseded by F-18 FDG PET/CT)
- Sarcoidosis and other granulomatous disease patterns in older literature
Why Use Is Declining
FDG PET/CT and labeled leukocytes usually offer better logistics or specificity for modern pathways. CNMT items still expect Ga-67 physics, transferrin mechanism, delayed multi-day imaging, and bowel activity as an interpretation confounder.
Traps
Wrong energy windows (missing peaks) tank counts. Recent chemotherapy, gadolinium, or iron overload can alter biodistribution. Normal liver, spleen, bone marrow, and lacrimal/nasal activity can confuse newcomers. Do not expect Ga-67 to be a first-line PE ventilation agent or MPI tracer.
Thallium-201 Thallous Chloride
Physics and Mechanism
Tl-201 (t½ ≈ 73 hours) decays by electron capture. Imaging relies mainly on mercury x-rays ~69–83 keV plus a 167 keV gamma. Soft-tissue attenuation is worse than for Tc-99m 140 keV photons.
Thallous ion (Tl⁺) is a potassium analog. Myocardial uptake uses the Na+/K+ ATPase pump and is proportional to blood flow and viable myocytes. Unlike Tc-99m sestamibi/tetrofosmin, Tl-201 shows clinically important redistribution: after a stress injection, serial imaging can show fill-in of ischemic but viable territories as tracer redistributes from other regions.
| Feature | Tl-201 teaching profile |
|---|---|
| Mechanism | K+ analog; Na+/K+ ATPase |
| Classic uses | Stress/redistribution MPI; viability (rest-redistribution protocols) |
| Typical adult activity | Often ~2–4 mCi (74–148 MBq) IV (lower than Tc MPI mCi amounts) |
| Imaging | Stress images early after injection; redistribution ~3–4 h (sometimes 24 h for viability) |
| Compared with Tc agents | Better redistribution physiology teaching; worse counts, attenuation, and dosimetry for many protocols |
Viability vs Perfusion Teaching Point
A fixed defect on Tc MPI may still be evaluated for viability with metabolic FDG PET or thallium rest-redistribution strategies—exam stems love “redistribution implies viable myocardium” language for thallium. Do not claim Tc-sestamibi has the same robust redistribution behavior.
Traps
Breast and diaphragm attenuation; low-energy scatter; confusing thallium with technetium dose magnitudes; injecting at wrong stress timing; and treating thallium as a ventilation or bone agent.
Xenon-133 Gas
Physics and Mechanism
Xe-133 is a noble-gas ventilation agent. Physical half-life ≈ 5.3 days; primary photon ≈ 81 keV. Patients inhale Xe-133 mixed in air/oxygen via a closed delivery system. Because xenon is lipophilic and inert, it distributes in aerated lung and washes out with ventilation; there is also potential fat solubility and soft-tissue background with delayed clearance in obese patients.
| Phase (classic Xe study) | What you see |
|---|---|
| Single-breath / washin | Initial ventilation map |
| Equilibrium | Rebreathing fills ventilated regions |
| Washout | Clearance; air trapping retains activity (e.g., obstructive disease) |
Adult administered activities are often in the 5–20 mCi inhaled range depending on system and protocol (know order of magnitude and that it is inhaled gas, not IV MAA).
Room Preparation and Engineering Controls
Xe-133 is a radioactive gas—contamination control is a regulatory and safety favorite:
| Control | Why it matters |
|---|---|
| Negative-pressure imaging room (relative to corridor) | Contains leaked gas |
| Dedicated exhaust / monitoring | Prevents department spread |
| Charcoal trap or approved trapping system on the delivery unit | Captures exhaled Xe-133 |
| Trap saturation checks / replacement schedule | Saturated traps release activity |
| Door discipline and spill/leak drills | Limit worker/public exposure |
| Pregnancy policies / posting | Gas studies have unique airborne pathways |
After a leak, survey and evacuate/ventilate per radiation-safety procedures—do not treat it like a liquid Tc spill only.
Xe-133 vs Tc Ventilation Alternatives
| Agent | Form | Strength | Limitation |
|---|---|---|---|
| Xe-133 | Gas | True gas washout physiology; widely tested | Room controls; 81 keV; soft-tissue background |
| Tc-99m DTPA aerosol | Nebulized liquid droplets | Uses Tc energy/collimators; easier room control | Central airway deposition if poor technique; not a true gas |
| Technegas (where available) | Ultrafine carbon particles | Excellent peripheral penetration | Availability/regulatory status varies |
PE workups pair ventilation with Tc-99m MAA perfusion. Know which mismatch patterns matter clinically, but this section’s job is agent + room physics.
Quick “When Would You Still See These?”
| Clinical need | Legacy agent | Common modern alternative |
|---|---|---|
| Infection / FUO / selected tumor | Ga-67 citrate | Labeled WBCs; F-18 FDG PET/CT |
| MPI with redistribution teaching / viability history | Tl-201 | Tc-99m sestamibi/tetrofosmin; FDG viability PET |
| Ventilation for V/Q | Xe-133 | Tc-99m DTPA aerosol or Technegas |
Bottom line for CNMT: even when your clinic rarely orders Ga-67 or Tl-201, the exam still expects half-life, energy, mechanism, and the xenon room checklist.
Which description best matches Ga-67 citrate localization for infection imaging?
Why is thallium-201 classically associated with myocardial redistribution imaging?
Before performing Xe-133 ventilation imaging, which room-preparation requirement is most characteristic of this agent?